Low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patients

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 5, 1998, Pages 465-468

  Simonsen, Gunnar S ^a,b   Andersen, Bjørg M ^c   Digranes, Asbjørn ^d   Harthug, Stig ^d   Jacobsen, Trond ^e   Lingaas, Egil ^f   Natås, Olav B ^g   Olsvik, Ørjan ^a,b   Ringertz, Signe H ^h   Skulberg, Andreas ⁱ   Syversen, Gaute ^c   Sundsfjord, Arnfinn ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g STAVANGER UNIVERSITY HOSPITAL   (Norway)

^h AKER UNIVERSITY HOSPITAL   (Norway)

ⁱ Helsetilsynet i Oslo og Akershus   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; FECES; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; NORWAY; NUCLEOTIDE SEQUENCE;

ANTI-BACTERIAL AGENTS; CARRIER STATE; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; FECES; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; NORWAY; PREVALENCE; VANCOMYCIN;

EID: 0032411890     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365549850161449     Document Type: Article

References (38)

1. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988; 1: 57-8.
2. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319: 157-61.
3. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. MMWR Morb Mortal Wkly Rep 1993; 42: 597-9.
4. Uttley AH, George RC, Naidoo J, Woodford N, Johnson AP, Collins CH, Morrison D, Gilfillan AJ, Fitch LE, Heptonstall J. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 1989; 103: 173-81.
5. Chadwick PR, Oppenheim BA, Fox A, Woodford N, Morgenstern GR, Scarffe JH. Epidemiology of an out-break due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit. J Hosp Infect 1996; 34: 171-82.
6. Lavery A, Rossney AS, Morrison D, Power A, Keane CT. Incidence and detection of multi-drug-resistant enterococci in Dublin hospitals. J Med Microbiol 1997; 46: 150-6.
7. Biavasco F, Miele A, Vignaroli C, Manso E, Lupidi R, Varaldo PE. Genotypic characterization of a nosocomial outbreak of vanA Enterococcus faecalis. Microb Drug Resist 1996; 2: 231-7.
8. Vuopio-Varkila J, Suppola J, Klinger N, Tarkka E, Kolho E. Increase of the number of vancomycin resistant enterococci (VRE) isolated in Helsinki, Finland. Eurosurveillance Monthly 1997; 2: 12.
9. Boisivon A, Thibault M, Leclercq R. Collége de Bactériologie-Virologie-Hygiène des Hôspitaux Généraux Français. Colonization by vancomycin-resistant enterococci of the intestinal tract of patients in intensive care units from French general hospitals. Clin Microbiol Infect 1997; 3: 175-9.
10. Endtz HP, van den Braak N, van Belkum A, Kluytmans JA, Koeleman JG, Spanjaard L, Voss A, Weersink AJ, Vandenbroucke-Grauls CM, Buiting AG, van Duin A, Verbrugh HA. Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands. J Clin Microbiol 1997; 35: 3026-31.
11. Klare I, Heier H, Claus H, Böhme G, Marin S, Seltmann G, Hakenbeck R, Antanassova V, Witte W. Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb Drug Resist 1995; 1: 265-72.
12. Van der Auwera P, Pensart N, Korten V, Murray BE, Leclercq R. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis 1996; 173: 1129-36.
13. Van den Bogard AE, Mertens P, London NH, Stobberingh EE. High prevalence of colonization with vancomycin- and pristinamycin-resistant enterococci in healthy humans and pigs in The Netherlands: is the addition of antibiotics to animal feed to blame? J Antimicrob Chemother 1997; 40: 454-6.
14. Kjerulf A, Pallesen L, Westh H. Vancomycin-resistant enterococci at a large university hospital in Denmark. APMIS 1996; 104: 475-9.
15. Torell E, Fredlund H, Tornquist E, Myhre EB, Sjoberg L, Sundsfjord A. Intrahospital spread of vancomycin-resistant Enterococcus faecium in Sweden. Scand J Infect Dis 1997; 29: 259-63.
16. Harthug S, Langeland N, Harris K, Digranes A. Vancomycin resistance emerging in a clonal outbreak caused by multiresistant enterococcus faecium. Abstract no. J-34, p 294. In: Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. Washington DC: American Society of Microbiology, 1997.
17. Melhus A, Tjernberg I. First documented isolation of vancomycin-resistant Enterococcus faecium in Sweden. Scand J Infect Dis 1996; 28: 191-3.
18. Haarr E, Simonsen GS, Olsvik Ø, Sundsfjord A, Harbo K, Natås OB. First infection with VanA vancomycin-resistant enterococci in a Norwegian hospital. Tidsskr Nor Laageforen 1998; 118: 1188-90.
19. Aarestrup FM. Occurence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microb Drug Resist 1995; 1: 255-7.
20. Aarestrup FM, Ahrens P, Madsen M, Pallesen LV, Poulsen RL, Westh H. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob Agents Chemother 1996; 40: 1938-40.
21. Kruse H, Rørvik LM. The use of avoparcin as a growth promoter and the occurence of vancomycin resistant Enterococcus spp. in poultry production. In: Program and Abstracts of the ASM 96th General Meeting, New Orleans, USA. Washington DC: American Society of Microbiology, Abstract C-196, 1996: 36.
22. Bates J, Jordens JZ, Griffiths DT. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother 1994; 34: 507-14.
23. Noskin GA. Vancomycin-resistant enterococci: clinical, microbiologic, and epidemiologic features. J Lab Clin Med 1997; 130: 14-20.
24. Montecalvo MA, Horowitz H, Gedris C, Carbonaro C, Tenover FC, Issah A, Cook P, Wormser GP. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994; 38: 1363-7.
25. Rhinehart E, Smith NE, Wennersten C, Gorss E, Freeman J, Eliopoulos GM, Moellering RC, Jr, Goldmann DA. Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical. N Engl J Med 1990; 323: 1814-8.
26. Wade JJ. The emergence of Enterococcus faecium resistant to glycopeptides and other standard agents - a preliminary report. J Hosp Infect 1995; Suppl 30: 483-93.
27. Ford M, Perry JD, Gould FK. Use of cephalexin-aztreonamarabinose agar for selective isolation of Enterococcus faecium. J Clin Microbiol 1994; 32: 2999-3001.
28. Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother 1993; 37: 2311-7.
29. Gold HS, Unal S, Cercenado E, Thauvin Eliopoulos C, Eliopoulos GM, Wennersten CB, Moellering RC, Jr. A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci. Antimicrob Agents Chemother 1993; 37: 1604-9.
30. Patel R, Uhl JR, Kohner P, Hopkins MK, Cockerill FR. Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/ 3 genes in enterococci. J Clin Microbiol 1997; 35: 703-7.
31. van Horn KG, Gedris CA, Rodney KM. Selective isolation of vancomycin-resistant enterococci. J Clin Microbiol 1996; 34: 924-7.
32. Landman D, Quale JM, Oydna E, Willey B, DiTore V, Zaman M, Patel K, Saurina G, Huang W. Comparison of five selective media for identifying fecal carriage of vancomycin-resistant enterococci. J Clin Microbiol 1996; 34: 751-2.
33. Ishi Y, Ohno A, Kashitani S, Iwata M, Yamaguchi K Identification of VanB-type vancomycin resistance in Enterococcus gallinarum from Japan. J Infect Chemother 1996; 2: 102-5.
34. Drug Consumption in Norway 1988-1992, Oslo: Norsk Medisinaldepot AS, 1993.
35. Drug Consumption in Norway 1992-1996, Oslo: Norsk Medisinaldepot AS, 1997.
36. Ena J, Houston A, Wenzel RP, Jones RN. Trends in gram-positive bloodstream organism resistance: a seven-year audit of five glycopeptides and other drugs at a large university hospital. J Chemother 1993; 5: 17-21.
37. Klare I, Heier H, Claus H, Witte W. Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides (published erratum appears in FEMS Microbiol Lett 1993; 107: 349). FEMS Microbiol Lett 1993; 80: 23-9.
38. Klare I, Heier H, Claus H, Reissbrodt R, Witte W. VanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry (published erratum appears in FEMS Microbiol Lett 1995; 127: 273). FEMS Microbiol Lett 1995; 125: 165-71.